Peter A. Schwartzman

Peter A. Schwartzman

Corporate Officer/Principal bij RADIUS HEALTH, INC.

Consumer Services
Finance
Health Technology

Oorsprong van het eerstegraads netwerk van Peter A. Schwartzman

EntiteitType entiteitIndustrie
The Leonard N Stern School of Business
203
College/University Other Consumer Services 203
Trinity College (Connecticut)
62
College/University Other Consumer Services 62
Holding Company Biotechnology 35

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Peter A. Schwartzman via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
New York University College/University

Seymour Jones

Kurt Y. Lin

Andre Haroche

Lewis Silberman

Yulia Germanovna Chupina

Masters Business Admin

Undergraduate Degree

Masters Business Admin

Graduate Degree

Masters Business Admin

NVN LIQUIDATION, INC. Pharmaceuticals: Major

George Martin

Sean Murphy

A. Sanders

Cole Ikkala

Chief Executive Officer

Director/Board Member

Director/Board Member

Investor Relations Contact

Pharmaceuticals: Major

George Martin

Sean Murphy

Andrew von Eschenbach

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

George Martin

Owen Hughes

Andrew von Eschenbach

Chairman

Director/Board Member

Director/Board Member

MALIN CORPORATION PLC Biotechnology

George Martin

Sean Murphy

Owen Hughes

Chief Executive Officer

Founder

Director/Board Member

Miscellaneous Commercial Services

Seymour Jones

Jeff Barry

James Chopas

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

TRISALUS LIFE SCIENCES, INC. Medical Specialties

George Martin

Sean Murphy

Andrew von Eschenbach

Director/Board Member

Director of Finance/CFO

Director/Board Member

Medical/Nursing Services

George Martin

Sean Murphy

Founder

Director/Board Member

Pharmaceuticals: Major

George Martin

Andrew von Eschenbach

Director/Board Member

Director/Board Member

POSEIDA THERAPEUTICS, INC. Biotechnology

George Martin

Sean Murphy

Director/Board Member

Director/Board Member

Investment Banks/Brokers

David Joyce

Jonathan Isaac Dubroff

Analyst-Equity

Analyst-Equity

MORGAN STANLEY Investment Managers

Catherine Friedman

Thomas Gray

Corporate Officer/Principal

Corporate Officer/Principal

Princeton University College/University

George Martin

Danielle Holtschlag

Undergraduate Degree

Undergraduate Degree

Investment Managers

Alex Albert

Laura Furmanski

Private Equity Investor

Private Equity Investor

Financial Conglomerates

George Martin

Sean Murphy

Chief Executive Officer

Director/Board Member

Fairfield University College/University

Joel Krikston

Keith Anthony Dubauskas

Undergraduate Degree

Undergraduate Degree

BIOGEN INC. Pharmaceuticals: Major

A. Sanders

Rohan Lathia

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

Jean-Pierre Garnier

Laura Furmanski

Masters Business Admin

Undergraduate Degree

The University of Texas at Austin College/University

Terence A. Kelly

Andrew von Eschenbach

Doctorate Degree

Corporate Officer/Principal

Copenhagen Business School College/University

Christian Dalum

Karina Kirk

Undergraduate Degree

Graduate Degree

Villanova University College/University

Scott T. Lowry

Scott Briggs

Undergraduate Degree

Undergraduate Degree

Georgetown University College/University

Rich Petrocelli

Jeff Barry

Undergraduate Degree

Graduate Degree

The Trustees of Columbia University in The City of New York College/University

Craig Lloyd Chodash

Alex Albert

Undergraduate Degree

Graduate Degree

THERMO FISHER SCIENTIFIC Medical Specialties

James Chopas

Mark Conley

Corporate Officer/Principal

Director of Finance/CFO

Investment Managers

Michael Rehaut

Jeffrey Craig Stevens

Analyst-Equity

Analyst-Equity

University of Michigan College/University

Ari Dean Sass

Averi Price

Undergraduate Degree

Graduate Degree

Dartmouth College College/University

Owen Hughes

Jennifer Jarrett

Undergraduate Degree

Undergraduate Degree

ELI LILLY AND COMPANY Pharmaceuticals: Major

Andrew von Eschenbach

Willard Dere

Corporate Officer/Principal

Corporate Officer/Principal

Harvard Business School College/University

Jessica Hopfield

Boris Groysberg

Masters Business Admin

Corporate Officer/Principal

Vanderbilt University College/University

Jeff Barry

Alex Albert

Masters Business Admin

Undergraduate Degree

CULLINAN THERAPEUTICS, INC. Pharmaceuticals: Major

Anthony Adam Rosenberg

Owen Hughes

Chairman

Founder

Investment Banks/Brokers

Jonathan Isaac Dubroff

Susan Vissers Lisa

Analyst-Equity

Corporate Officer/Principal

Investment Managers

Dave Lemons

Owen Hughes

Corporate Officer/Principal

Portfolio Manager-Equities

Miscellaneous Commercial Services

Jessica Hopfield

Laura Furmanski

Corporate Officer/Principal

Private Equity Investor

Investment Managers

Triantafillos Nicholas Spiridellis

Matthew Kimble

Analyst-Equity

Portfolio Manager-Fixed Income

Miscellaneous Commercial Services

Jonathan Isaac Dubroff

Ari Dean Sass

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Daphne Quimi

Corporate Officer/Principal

Packaged Software

Joel Krikston

Director/Board Member

Miscellaneous Commercial Services

Daphne Quimi

Corporate Officer/Principal

Specialty Telecommunications

Joel Krikston

Director/Board Member

Packaged Software

Joel Krikston

Director/Board Member

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Daphne Quimi

Corporate Officer/Principal

Packaged Software

Joel Krikston

Director/Board Member

Medical Distributors

Joel Krikston

Director/Board Member

Statistieken

Internationaal

Verenigde Staten 44
Ierland 5
Verenigd Koninkrijk 2
België 2
Denemarken 2

Sectoraal

Consumer Services 14
Health Technology 14
Finance 14
Commercial Services 6
Technology Services 4

Operationeel

Director/Board Member 275
Corporate Officer/Principal 172
Undergraduate Degree 89
Independent Dir/Board Member 80
Masters Business Admin 63
-40 % Uitzonderlijk verlengd: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU